PDS Biotechnology Corp Earnings Per Share, Basic and Diluted
PDS Biotechnology Corp (PDSB) reported Earnings Per Share, Basic and Diluted of -$0.89 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-18
- PDS Biotechnology Corp earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.21.
- PDS Biotechnology Corp earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$1.10.
- PDS Biotechnology Corp earnings per share, basic and diluted for the quarter ending 2018-09-30 was -$0.21.
- PDS Biotechnology Corp earnings per share, basic and diluted for the quarter ending 2017-12-31 was -$0.44.
- PDS Biotechnology Corp earnings per share, basic and diluted for fiscal 2020 was -$0.89.
- PDS Biotechnology Corp earnings per share, basic and diluted for fiscal 2019 was -$1.44, a 225.22% decline from fiscal 2018.
- PDS Biotechnology Corp earnings per share, basic and diluted for fiscal 2018 was $1.15.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | -$0.89 10-K · filed 2021-03-18 | ||||
| 2020-09-30 | -$0.21 10-Q · filed 2020-11-13 | -$0.73 10-Q · filed 2020-11-13 | |||
| 2019-12-31 | -$1.44 10-K · filed 2021-03-18 | $1.44 10-K · filed 2020-03-27 | |||
| 2019-09-30 | -$1.10 10-Q · filed 2020-11-13 | -$0.60 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $1.15 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | -$0.21 10-Q · filed 2019-11-07 | -$0.62 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$0.81 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$1.25 derived: net income ÷ weighted average shares · filed 2019-02-21 | -$1.67 derived: net income ÷ weighted average shares · filed 2019-02-21 | |
| 2017-09-30 | -$0.37 derived: net income ÷ weighted average shares · filed 2018-11-01 | -$0.81 derived: net income ÷ weighted average shares · filed 2018-11-01 | -$1.23 derived: net income ÷ weighted average shares · filed 2018-11-01 | -$1.56 derived: net income ÷ weighted average shares · filed 2018-11-01 | |
| 2017-06-30 | -$0.44 derived: net income ÷ weighted average shares · filed 2018-08-01 | -$0.86 derived: net income ÷ weighted average shares · filed 2018-08-01 | -$1.20 derived: net income ÷ weighted average shares · filed 2018-08-01 | -$1.57 derived: net income ÷ weighted average shares · filed 2018-08-01 | |
| 2017-03-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2018-05-01 | -$0.75 derived: net income ÷ weighted average shares · filed 2018-05-01 | -$1.12 derived: net income ÷ weighted average shares · filed 2018-05-01 | -$1.45 derived: net income ÷ weighted average shares · filed 2018-05-01 | |
| 2016-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.70 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.03 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.34 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2016-09-30 | -$0.37 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.70 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.02 derived: net income ÷ weighted average shares · filed 2017-11-01 | -$1.31 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2016-06-30 | -$0.33 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.64 derived: net income ÷ weighted average shares · filed 2017-08-01 | -$0.94 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.78 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2016-03-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.61 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.52 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$2.45 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2015-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.38 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$2.67 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$4.01 derived: net income ÷ weighted average shares · filed 2018-03-01 | |
| 2015-09-30 | -$7.08 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$11.39 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$14.44 derived: net income ÷ weighted average shares · filed 2016-11-01 | -$16.61 derived: net income ÷ weighted average shares · filed 2017-03-02 | |
| 2015-06-30 | -$4.30 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$7.36 derived: net income ÷ weighted average shares · filed 2016-08-03 | -$9.52 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$11.82 derived: net income ÷ weighted average shares · filed 2017-03-02 | |
| 2015-03-31 | -$3.05 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$5.22 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$7.52 derived: net income ÷ weighted average shares · filed 2017-03-02 | ||
| 2014-12-31 | -$2.17 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$4.47 derived: net income ÷ weighted average shares · filed 2017-03-02 | -$8.16 derived: net income ÷ weighted average shares · filed 2017-03-02 | ||
| 2014-09-30 | -$2.30 derived: net income ÷ weighted average shares · filed 2016-03-08 | -$5.99 derived: net income ÷ weighted average shares · filed 2015-11-06 | |||
| 2013-12-31 | -$4.71 derived: net income ÷ weighted average shares · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |